gallocatechol has been researched along with Iron Metabolism Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abraham, B; Alayash, AI; Baek, JH; Buehler, PW; Manalo, DJ; Struble, E | 1 |
1 other study(ies) available for gallocatechol and Iron Metabolism Disorders
Article | Year |
---|---|
Inactivation of prolyl hydroxylase domain (PHD) protein by epigallocatechin (EGCG) stabilizes hypoxia-inducible factor (HIF-1α) and induces hepcidin (Hamp) in rat kidney.
Topics: Animals; Antimicrobial Cationic Peptides; Catechin; Cell Line; Gene Expression Regulation; Hepcidins; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Iron Metabolism Disorders; Kidney; Male; Procollagen-Proline Dioxygenase; Protein Stability; Protein Structure, Secondary; Protein Structure, Tertiary; Rats; Rats, Sprague-Dawley | 2011 |